Nasus is a late bloomer in League of Legends. The champion can be one of the most powerful tanks in the game if players use him correctly. Gamers need to take a conservative approach in the first five ...
Joe Grantham is a contributor from the UK with a degree in Classical Studies. His love for gaming is only rivaled by a deep passion for medieval history, which often seeps into his articles. With over ...
Hosted on MSN
Nasus Pharma initiated with a Buy at Laidlaw
Laidlaw analyst Yale Jen initiated coverage of Nasus Pharma (NSRX) with a Buy rating and $22 price target The firm says Nasus is a mid-clinical stage biotech company focusing on the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback